Prophylactic antiparasitic transgenesis for human parasitic disease?

Molecular Therapy

Volumn 18, Issue 10, 2010, Pages 1745-1747

  Lukeš, Julius ^a   Raper, Jayne ^b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; APOLIPOPROTEIN; APOLIPOPROTEIN L1; PROTEIN N MYRISTOYLTRANSFERASE; UNCLASSIFIED DRUG;

ADENOSINE DEAMINASE DEFICIENCY; DNA MODIFICATION; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE TRANSFER; GENETIC VARIABILITY; HETEROZYGOSITY; HOST RESISTANCE; HUMAN; KIDNEY DISEASE; NONHUMAN; NOTE; PARASITOSIS; POPULATION GENETICS; PROTEIN BINDING; SOMATIC GENE THERAPY; TRANSGENE; TRYPANOSOMA BRUCEI;

EID: 77957590953     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.193     Document Type: Note

References (17)

1. Pérez-Morga, D, Vanhollebeke, B, Paturiaux-Hanocq, F, Nolan, DP, Lins, L, Homblé, F et al. (2005). Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membrane. Science 309: 469-472.
2. Molina-Portela, MP, Samanovic, M and Raper, J (2008). Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J Exp Med 205: 1721-1728.
3. Vanhollebeke, B, Truc, P, Poelvoorde, P, Pays, A, Joshi, PP, Katti, R et al. (2006). Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-1. N Engl J Med 355: 2752-2756.
4. Oli, MW, Cotlin, LF, Shiflett, AM and Hajduk, SL (2006). Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei. Eukaryot Cell 5: 132-139.
5. Lecordier, L, Vanhollebeke, B, Poelvoorde, P, Tebabi, P, Paturiaux-Hanocq, F, Andris, F et al. (2009). C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathogens 5: e1000685.
6. Thomson, R, Molina-Portela, P, Mott, H, Carrington, M and Raper, J (2009). Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc Natl Acad Sci USA 106: 19509-19514.
7. Genovese, G, Friedman, DJ, Ross, MD, Lecordier, L, Uzureau, P, Freedman, BI et al. (2010). Association of trypanolytic ApoL1 variants with kidney disease in African-Americans. Science 329: 841-845.
8. Tzur, S, Rosset, S, Shemer, R, Yudkovsky, G, Selig, S, Tarekegn, A et al. (2010). Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345-350.
9. Taylor, JE and Rudenko, G. (2006). Switching trypanosome coats: what's in the wardrobe? Trends Genet 22: 614-620.
10. Stuart, K, Brun, R, Croft, S, Fairlamb, A, G?rtler, RE, McKerrow, J et al. (2008). Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 118: 1301-1310.
11. Frearson, JA, Brand, S, McElroy, SP, Cleghorn, LA, Smid, O, Stojanovski, L et al. (2010). N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 464: 728-732.
12. Hacein-Bey-Abina, S, Le Deist, F, Carlier, F, Bouneaud, C, Hue, C, De Villartay, JP et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346: 1185-1193. (Pubitemid 34984579)
13. Aiuti, A, Cattaneo, F, Galimberti, S, Benninghoff, U, Cassani, B, Callegaro, L et al. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360: 447-458.
14. Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN Jr, Mingozzi, F, Bennicelli, J et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
15. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
16. Frankel, M (2003). Inheritable genetic modification and a brave New World: did Huxley have it wrong? Hastings Cent Rep 33: 31-36.
17. Collins, FS (2010). The Language of Life: DNA and the Revolution in Personalized Medicine. HarperCollins: New York.